Literature DB >> 32538257

The impact of laparoscopic surgery on the symptoms and wellbeing of patients with deep infiltrating endometriosis and bowel involvement.

Rogério Serafim Parra1,2, Marley Ribeiro Feitosa1,2, Hugo Parra de Camargo2, Fernando Passador Valério3,4, José Vitor Cabral Zanardi3,4, José Joaquim Ribeiro da Rocha1,2, Omar Féres1.   

Abstract

BACKGROUND: The purpose of this study was to evaluate the symptoms and wellbeing of patients who underwent laparoscopic colorectal resection for deep endometriosis infiltrating the rectum and/or colon in a single reference center.
METHODS: We conducted a cross-sectional survey based on a structured questionnaire. All patients underwent laparoscopic discoid resection, segmental resection or shaving for deep endometriosis in a single reference center between October 2014 and October 2019. The following topics were addressed: symptoms related to endometriosis, fertility, disease recurrence and quality of life. The Institutional Review Board approved the study and signed informed consent was required before enrollment.
RESULTS: A total of 77 of 160 (48.1%) subjects agreed to answer the questionnaire and were enrolled in the study. The mean age was 36.4 years (range, 24-54 years), and 45.5% of the patients had previously undergone surgery for deep endometriosis. Complete resolution of abdominal pain was observed in 48.1% of subjects after surgery. Pelvic pain was rated on a scale of 0 (no pain) to 10 (worst pain) before and after the procedure. In this evaluation, mean pain scores were reduced after surgery (9.21 ± 1.53 × 3.99 ± 3.14; p < .001). Other positive aspects reported by interviewees were increased willingness to perform daily activities (66.2%), increased physical activity (70.1%), better work performance (72.7%), improved dyspareunia (77.9%) and increased sexual activity (71.4%). Some negative aspects reported after surgery were straining at stool (35.1%), nocturia (24.7%), liquid-feces incontinence (13%), mild urinary incontinence (13%), urinary urgency (11.7%) and flatus incontinence (7.8%). Regarding pregnancy, 59% of patients tried to conceive after surgery, and the success rate was 28.2% (46.2% spontaneous and 53.8% after in vitro fertilization or insemination).
CONCLUSIONS: Laparoscopic surgery was associated with pain reduction and improved general wellbeing in patients diagnosed with deep endometriosis and bowel involvement.

Entities:  

Keywords:  Endometriosis; colorectal surgery; deep-infiltrating endometriosis; laparoscopy; psychological wellbeing

Year:  2020        PMID: 32538257     DOI: 10.1080/0167482X.2020.1773785

Source DB:  PubMed          Journal:  J Psychosom Obstet Gynaecol        ISSN: 0167-482X            Impact factor:   2.949


  4 in total

1.  Analysis of preoperative and postoperative quality of life, sexual function, and sleep in patients with endometriosis: a prospective cohort study.

Authors:  Belfin Nur Arici Halici; Fatih Aktoz; Meric Kabakci; Gurkan Kiran; Pinar Ozcan
Journal:  Arch Gynecol Obstet       Date:  2022-04-22       Impact factor: 2.344

2.  Chronic Pelvic Pain in Women with Endometriosis is Associated with Psychiatric Disorder and Quality of Life Deterioration.

Authors:  R Muharam; Titi Amalia; Gita Pratama; Achmad Kemal Harzif; Feranindhya Agiananda; Mila Maidarti; Mazaya Azyati; Kanadi Sumapraja; Hariyono Winarto; Budi Wiweko; Andon Hestiantoro; Eva Suarthana; Togas Tulandi
Journal:  Int J Womens Health       Date:  2022-02-04

3.  Radical surgery for pseudo-ovarian malignancy: a case report of bowel endometriosis with massive ascites.

Authors:  Yiting Bao; Wu Huang; Liangqing Yao; Lei Yuan
Journal:  Gland Surg       Date:  2022-05

4.  Health-Related Quality of Life in Adult Spanish Women with Endometriomas or Deep Infiltrating Endometriosis: A Case-Control Study.

Authors:  Evdochia Adoamnei; Inés Morán-Sánchez; María Luisa Sánchez-Ferrer; Jaime Mendiola; María Teresa Prieto-Sánchez; Miriam Moñino-García; Joaquín A Palomar-Rodríguez; Alberto Manuel Torres-Cantero
Journal:  Int J Environ Res Public Health       Date:  2021-05-24       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.